
Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding
New data presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) yesterday show that two long-acting injectable PrEP options, lenacapavir and cabotegravir, are safe, well tolerated and effective for use during pregnancy and …